265 related articles for article (PubMed ID: 8950987)
21. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.
Lee TH; Pelletier J
Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605
[TBL] [Abstract][Full Text] [Related]
22. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
Deuel TF; Guan LS; Wang ZY
Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
Sakamoto Y; Yoshida M; Semba K; Hunter T
Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
[TBL] [Abstract][Full Text] [Related]
25. Functional properties of WT1.
Haber DA; Englert C; Maheswaran S
Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
[TBL] [Abstract][Full Text] [Related]
26. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
28. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
29. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.
Kim JM; Hong Y; Semba K; Kim S
Biochem Biophys Res Commun; 2000 Jan; 267(1):59-63. PubMed ID: 10623574
[TBL] [Abstract][Full Text] [Related]
30. Wilms' tumor suppressor gene (WT1) as a target gene of SRY function in a mouse ES cell line transfected with SRY.
Toyooka Y; Tanaka SS; Hirota O; Tanaka S; Takagi N; Yamanouchi K; Tojo H; Tachi C
Int J Dev Biol; 1998 Nov; 42(8):1143-51. PubMed ID: 9879712
[TBL] [Abstract][Full Text] [Related]
31. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
32. Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcript.
Algar EM; Kenney MT; Simms LA; Smith SI; Kida Y; Smith PJ
Hum Mutat; 1995; 5(3):221-7. PubMed ID: 7599632
[TBL] [Abstract][Full Text] [Related]
33. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
Dejong V; Degeorges A; Filleur S; Ait-Si-Ali S; Mettouchi A; Bornstein P; Binétruy B; Cabon F
Oncogene; 1999 May; 18(20):3143-51. PubMed ID: 10340386
[TBL] [Abstract][Full Text] [Related]
34. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
35. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.
Tsutsui J; Kadomatsu K; Matsubara S; Nakagawara A; Hamanoue M; Takao S; Shimazu H; Ohi Y; Muramatsu T
Cancer Res; 1993 Mar; 53(6):1281-5. PubMed ID: 8383007
[TBL] [Abstract][Full Text] [Related]
36. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
38. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
[TBL] [Abstract][Full Text] [Related]
39. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
Little MH; Holmes G; Pell L; Caricasole A; Duarte A; Law M; Ward A; Wainwright B
Oncogene; 1996 Oct; 13(7):1461-9. PubMed ID: 8875984
[TBL] [Abstract][Full Text] [Related]
40. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]